Cisplatin and Etoposide Chemotherapy in the Treatment of Adult Wilms’ Tumor
Author(s) -
Adil Esen,
Cem Güler,
Aydanur Kargı,
Ziya Kırkalı
Publication year - 1996
Publication title -
urologia internationalis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.771
H-Index - 53
eISSN - 1423-0399
pISSN - 0042-1138
DOI - 10.1159/000282890
Subject(s) - etoposide , medicine , cisplatin , chemotherapy , nephrectomy , wilms' tumor , oncology , surgery , kidney
A 64-year-old man underwent left radical nephrectomy for stage III anaplastic Wilms' tumor. He received adjuvant chemotherapy consisting of cisplatin and etoposide. Complete clinical response was achieved and maintained for 12 months. A systemic relapse after 1 year also responded to three more cycles of cisplatin and etoposide. Although cisplatin- and etoposide-based chemotherapy was not used as a first-line therapy in adult patients with Wilms' tumor described in the literature, this case demonstrates the promising activity of this combination also in adults with this disease entity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom